So what is the game plan of big pharma and their hedge fund friends keeping share price down?
Obviously this has been going on for years and still continuing. Historical valuations of a biotech at this stage should value Msb at 3 to 5 billion imo.
My first guess is hostile bid takeover perhaps opening bid 5 x current price or 16 dollars.
And unfortunatley a bid of that amount may succeed. Personally I hope not.
Second scenario is big pharma keeping share price down to put pressure on Meso to complete a partnership deal.
This is better than a hostile takeover.
What I do believe is the 8 year strategy of starving cell therapy companies from capital is now going to come to an end and play out.
Covid forced the end game to play out sooner.
Intresting times ahead. Good luck to my fellow visionaries
So what is the game plan of big pharma and their hedge fund...
-
- There are more pages in this discussion • 16,059 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.26 |
Change
-0.050(3.83%) |
Mkt cap ! $1.432B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.30 | $1.17 | $21.32M | 17.21M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 5460 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.26 | 978 | 1 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |